Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Immunology (aimen n) - use these > Transplantation & Immunosuppressive Drugs > Flashcards

Transplantation & Immunosuppressive Drugs Flashcards

(81 cards)

Start Studying
1
Q

What is transplantation?

A

Transplantation is the introduction of biological material (eg organs, tissue, cells) into an organism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does the immune system hinder transplantation?

A

The immune system has evolved to remove non-self

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the different types of donor/recipient relationships?

A

-Autologous
-Syngeneic
(In these 2 donor/recipient relationships , donor and recipient is genetically identical = no immunological reactions)
-Allogeneic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is an autologous transplantation?

A

Transplant biological material from one part of the organism into the same organism

e.g. skin graft - take skin from 1 part of the body and graft it onto another part of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why is an immune response against autologous transplants unlikely?

A

May be inflammatory responses but no expected immune response as it is self transplant e.g. skin transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a syngeneic transplant?

A

Donor biological material is transplanted into recipient when donor and recipient are genetically identical e.g. twins

  • no immunological reaction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is an allogeneic donor/recipient relationship?

A

Donor and recipient are from the same species but are genetically different e.g. relatives: close genetic match (e.g. brother/sister)

= immune system reacts to the donated biological material

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is a xenogeneic donor/recipient relationship?

A

Donor and recipient are different species

e.g. pigs/bovine heart valves into humans in heart valve transplantation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is histocompatibility?

A

Histocompatibility = tissue compatibility (compatibility b/w donor tissue and the recipient)

MHC = major histocompatibility antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why do immune responses occur against transplants?

A

Immune responses to transplant are caused by genetic differences (histocompatibility differences) between the donor and the recipient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the major cause of transplant rejection?

A

MHC incompatibility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the human MHC?

A

Human MHC = Human Leukocyte Antigen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the diversity of HLA classes

A

3 class I HLA alleles: HLA A, B & C

3 Class II HLA alleles (dimers)

  • Thousands of Class I + Class II HLA alleles in a region of chr 6
  • Each individual has 2 HLA A alleles + 2 HLA B alleles, + 2 HLA C alleles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which cells express the different MHC molecules?

A

All nucleated cells express MHC Class I but only immune cells express MHC II molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe HLA Class I expression frequency

A

Even most common (A2) HLA can be classified into dozens of subtypes - lots of variability despite same HLA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What epitopes are present on donor MHC molecules?

A

B-cell epitopes on donor MHC

T-cell epitopes derived from donor MHC

1000’s of HLA alleles but perhaps only 100’s of epitopes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What technique is used to identify differences b/w donor HLA(MHC) and recipient HLA(MHC) alleles?

A

Next generation sequencing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the role of T cells in MHC Interaction?

A

T cells recognise foreign (non-self) peptides that are bound to self-MHC

CD8+ T-cells (cytotoxic T-cell) TCR interacts w MHC I(HLA) + the epitope it is expressing
CD4+ T-cells (helper T-cells) TCR interacts w MHC II (HLA) + the epitope in its binding groove

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How do APCs express MHC molecules?

A

APC will express MHC (I/II) molecules where peptides bind in their variable region grooves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How do T cells recognise MHC molecules?

A

TCR detects both peptide and MHC complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What cells do MHC I molecules activate?

A

MHC I activates TCR CD8+ cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What cells do MHC II activate?

A

MHC II activates TCR CD4+ cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What molecules do T cells recognise by MHC I presentation?

A

T cells recognise short peptide fragments that are presented to them by MHC) proteins (intracellular pathogens) e.g. viral infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How are viral proteins processed?

A

Viral proteins are degraded by proteasome into peptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
How do MHC bind to viral peptides?
Peptides attract and bind MHC molecules that are then transported to cells surface CD8 T cells can now interact
26
How are external pathogens cross presented?
Professional APCs (dendritic) can internalise external peptides and cross present onto MHC Class I pathway => CD8+ activation
27
Where does MHC II loading occur?
Only on professional APCs & WBCs | - immune cells
28
Describe the process of MHC II loading
1. External antigens processed in phagolysosome into peptides 2. Peptides interact with vesicles containing MHC and CLIP 3. Vesicular complex transferred to surface 4. CD4+ T cells activated
29
What is the role of the CLIP protein in MHC II loading?
Maintains HLA shape until peptide is ready to bind
30
What molecules do MHC I bind?
Fragments of intracellular proteins
31
Which molecules do MHC II bind?
Fragments of proteins which have been taken up by phagocytosis (APC)
32
What is the role of T helper cells (CD4+ T-cells)?
Helper T cells (CD4+ T-cells) are required to produce antibody and cytotoxic T-cell responses CD4+ T-helper cells orchestrate the nature of the immune response - Provide information about the nature of the infection by presenting epitopes (peptides) on HLA II - Provides support to other immune cells via cytokine production = activates/inhibits B-cell responses, activates/inhibits cytotoxic T-cell responses (depending on cytokine production - IL2 / IFNgamma / IL10)
33
What is the role of cytotoxic T cells?
Highly specific killer cells Lyse cells that present epitope (peptide) on their HLA I that the T-cell is specific to Cytotoxic T-cells kill virally-infected cells/cancer cells/transplant(foreign) cells
34
What is the 'foreign' proteins are detected in transplant rejection?
In transplants, both the MHC protein and the peptide in its binding groove may be foreign detected by TCR or antibody binding = various mechanisms by which the recipient's immune system can reject donor transplantation
35
Describe how recipient cells may induce T cell activation
Recipient Cell: No T-cell activation - Self HLA + self peptide T-cell activation - Self HLA + non self peptide
36
How may donor cells induce T cell activation?
Donor cell: No T-cell activation - Matched HLA + peptide T-cell activation - Unmatched HLA + peptide
37
How are donors matched to recipients?
``` Usually try to match 4/6 MHC class II loci, reduces likelihood of future transplants and problems with future transplants - HLA mismatch reduces graft survival ```
38
What is the inflammation state of transplant recipients?
Recipients will have a history of disease which will have resulted in a degree of inflammation
39
What is the caution of using deceased donors?
Organs from deceased donors are also likely to be in inflamed condition due to ischemia
40
How is transplant success affected by live / deceased donors?
Transplant success is less sensitive to MHC mismatch for live donors
41
What are the 3 types of transplant rejection?
1. Hyperacute rejection 2. Acute rejection 3. Chronic rejection
42
How soon after transplant does a hyperacute rejection occur?
Within a few hours of transplant
43
When is hyperacute rejection commonly seen?
Most commonly seen for highly vascularised organs (e.g. kidney) (highly vascularised = greater immune system access)
44
What causes a hyperacute rejection?
Pre-existing antibodies, usually to ABO blood group antigens or MHC-I proteins (ABO antigens are expressed on endothelial cells of blood vessels in the transplanted tissue)
45
Where do MHC antibodies come from?
Antibodies to MHC can arise from pregnancy, blood transfusion or previous transplants
46
How do antibodies cause damage to transplanted tissues?
Antibody binds to the non-self MHC/ABO antigen = Fc antibody region(not bound) is recognised by Complement/NK cells Recognition of Fc region leading to - 1. Complement activation 2. Antibody-dependent cytotoxicity (Fc Receptors on NK cells) 3. Phagocytosis (Fc Receptors on macrophages)
47
Describe how a hyperacute rejection occurs
1. Antibodies bind to endothelial cells 2. Complement fixation 3. Accumulation of innate immune cells (NK cells, phagocytes) - phagocytose + lyse endothelial cells in transplanted tissue 4. Endothelial damage, platelets accumulate, thrombi develop = tissue death, transplant failure
48
What is acute rejection?
Inflammation activates the transplant organ’s resident dendritic cells DCs induce a T cell response due to MHC mismatch
49
Outline how direct allorecognition of a foreign MHC occurs
1. Kidney graft dendritic cells activated 2. DC migrate to spleen and activate effector T cells 3. Effector T cells migrate to graft via blood 4. Graft destroyed by macrophages + CTLs 1. Inflammation activates transplant organ's DCs 2. DCs migrate to secondary lymphoid tissue + encounter recipient T-cells 3. T-cells recognise foreign MHC = induces direct allorecognition 4. T-cells + macrophages target transplanted tissue + destroy transplant
50
When does chronic rejection occur?
Occurs months/years after transplant
51
What are the effects of chronic rejection?
Blood vessel walls thickened, lumina narrowed – loss of blood supply Correlates with presence of antibodies to MHC-I
52
How does chronic rejection arise?
Chronic rejection results from indirect allorecognition of foreign MHC/HLA
53
Describe how indirect allorecognition occurs
1. Donor-derived cells die 2. Membrane fragments containing donor MHC are taken up by host DC 3. Donor MHC is presented into peptides presented by host MHC 4. T cell response generated to peptide derived from processed donor MHC
54
What is HSCT?
Haematopoietic Stem Cell Transfer (HSCT) Previously called bone marrow transplant, now renamed as source is often blood. Often autologous
55
What are the advantages of HSCT?
HSCs find their way to bone marrow after infusion and regenerate there HSCs can be cryopreserved with little damage
56
What is GVHD?
Graft Vs. Host Disease When transplanted tissue is immune cells themselves, there is the risk of donor immune cells attacking the host The host (transplant recipient) is seen as non-self = GVHD. Transplant is targeting the host (NOT THE HOST/RECIPIENT TARGETING THE TRANSPLANT)
57
How to reduce GVHD?
Can be lethal – best approach is prevention Remove T cells from transplant or Suppress T-cell function using immunosuppressive drugs
58
What is GVL?
Graft Vs. Leukaemia
59
Why is GVL sometimes a good thing?
Sometimes mismatch and donor leukocytes can be beneficial - removing original leukemia Development of GVL may prevent disease relapse (the graft can identify + kill leukaemia cells, which necessitated the graft in the first place) graft sees leukaemia as non-self. recipient's original immune response partially sees leukaemia as self = weaker immune response against tumour cells.
60
What is the significance of immunosuppression for transplants/?
Essential to maintain non-autologous (allogeneic) transplant. 3 phases of treatment: - Induction - Antibody induction therapy + Triple drug regimen(calcineurin inhibitor + antiproliferative agent + corticosteroid)(high doses) - Maintenance - Triple drug regimen at lower doses - Rescue - T-cell mediated rejection = treat with ATG + high dose steroids. B-cell mediated rejection = treat with IV Ig(derived from other ppl) OR anti-CD20 monoclonal antibodies(depletes B-cells by binding to CD20 on B-cells) + high dose corticosteroids(for both) rescue phase if transplant rejection occurs
61
What immunosuppressors are used for transplants?
General immune inhibitors: - e.g. corticosteroids Cytotoxic = specific: - kill proliferating lymphocytes - e.g. mycophenolic acid, cyclophosphamide, methotrexate Inhibit T-cell activation: - cyclosporin, tacrolimus, rapamycin
62
What is a cost-effective drawback of using immunosuppressives?
Immunosuppressives may need to be maintained indefinitely
63
What is cyclosporin?
Inhibits recipient immune response to donor transplant. Blocks T cell proliferation and differentiation. Breakthrough drug for transplant - enables transplants to survive for longer in recipients. Next generation therapies developed are less toxic and effective at lower doses.
64
T-cells and MHC I Cell processes the protein and cell's MHC I presents the peptide to T-cells
1. T-cells recognise short peptide fragments that are presented to them by cell 2. In the cell, the protein is internalised in the cell - acts as a viral protein/is MHC protein itself 3. Proteasome degrades the protein into peptides 4. ER transports these peptides to MHC I 5. MHC I travels to cell surface 6. TCR recognises MHC I + the peptide it presents 2-6 occur in the cell
65
T-cells and MHC II
1. Antigen is internalised from extracellular spaces by phagolysosome 2. Protein is lysed into peptides 3. These peptides are transferred to MHC II 4. MHC II-peptide complex is presented on APC cell surface MHC II , CD4 , Extracellular antigens (e.g. antibody-bound viral particles/dead cells
66
What is allorecognition?
Allorecognition = T-cells are activated to respond to transplanted material - Direct allorecognition - Indirect allorecognition
67
Recipient Cell
Self-HLA presents self-peptide to self-TCR = no immune response. If immune response occurs here = autoimmunity Self-HLA + self-peptide = no T-cell activation Self-HLA presents foreign peptide to self-TCR. Self-HLA + non-self peptide = T-cell activation.
68
Indirect allorecognition
Partial matching b/w donor + recipient HLA 1 HLA which does match (self) could present a foreign peptide which does not match. Immune system recognises as foreign. The T-cells activated to this self-HLA, non-self peptide then find this same combination on transplanted cells
69
Donor cells
If the donor cell has matched HLA + self-peptide , no T-cell activation If matched donor HLA presents a foreign peptide(from an unmatched HLA) = targeting of transplant in indirect allorecognition Unmatched donor HLA presents non-self epitope from the HLA itself = TCR binding/antibody binding of unmatched HLA = causes direct allorecognition
70
The more donor/recipient HLA mismatches =
The more donor/recipient HLA mismatches = the less successful the transplant will be, lower graft survival
71
What happens in chronic rejection?
Alloantibodies bind to antigens + endothelial cells of the transplanted organ and recruit other immune effector cells - macrophages, cytotoxic T-cells, which induce damage + reduce blood supply to the organ. Alloantibodies to MHC I of the transplanted organ For chronic rejection, the MHC protein + its peptide in the binding groove may be foreign In chronic rejection, the Anti-transplant immune responses are induced from a type of indirect allorecognition Donor-derived cells die (e.g. donor HLA) + the dying cells are internalised by recipients' DCs = donor HLA is presented on recipient HLA = recipient HLA induces T-cell + antibody responses generated from the peptides derived from donor's MHC
72
What do HSCs do when they reach the bone marrow after infusion?
produce common precursors for lymphocytes = B-cells, T-cells, activated effector T-cells, plasma cells that produce Abs, granulocyte progenitors, basophils, neutrophils, eosinophils, monocytes, DCs, macrophages, mast cells, RBCs
73
Combination immunosuppressive regimes
1 - Steroids 2 - Cytotoxic 3 - Immunosuppressive specific for T-cells
74
What does calcineurin inhibitor inhibit?
Calcineurin inhibitor inhibits IL2 production
75
What do antiproliferatives do?
antiproliferatives inhibit B-cell/T-cell proliferation
76
what do corticosteroids do?
corticosteroids = anti-inflammatory
77
what do monoclonal antibodies do?
monoclonal antibodies = costimulation blockers
78
what do antithymocyte globulins do?
antithymocyte globulins inhibit/deplete T-cells
79
What are the negative consequences of immunosuppression?
Immunosuppression to prevent transplant rejection also reduces recipient ability to fight infection/tumorigenesis. -Transplant patients are more susceptible to CMV infection Immunosuppressive drug toxicity causes organ failure e.g. cyclosporin induces nephrotoxicity in kidney transplant
80
What new area has been found to be involved in transplant immunity?
The microbiome of the intestine is involved in regulating adaptive immune responses = may be useful in transplantation outcomes
81
Summary
• Transplant rejection results from genetic differences between donor and recipient – variability between MHC proteins is the major genetic difference in transplant rejection • Host attacks transplant – rejection (hyperacute, acute, chronic) • Transplant attacks host – GVHD • Immunosuppression can prolong the survival of transplanted organs

Immunology (aimen n) - use these (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions